Internal Medicine, Cardiovascular Disease · Anniston, AL
NPI
1750347183
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
901 Leighton Ave Ste 702
Anniston, AL, 36207
Phone (256) 231-2577
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
5,675 services
Medicare patients, 2024
1,441
Average age 75
Drug cost, 2024
$1.3M
9,903 prescriptions
Company payments, 2025
$319
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John I Nwogu was code 93010 (electrocardiogram), 1,228 times for 757 patients. In total John I Nwogu billed 5,675 services in 70 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,228 | 757 | $5.68 | $6,979 |
| 93010 Electrocardiogram | Office | 934 | 547 | $5.23 | $4,883 |
| 99214 Office E&M - Established | Office | 747 | 476 | $60.34 | $45K |
| 99233 Hospital E&M - Subsequent | Facility | 481 | 146 | $84.39 | $41K |
| 93306 Echocardiography (TTE/TEE) | Office | 280 | 272 | $44.47 | $12K |
| 93306 Echocardiography (TTE/TEE) | Facility | 230 | 214 | $47.97 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 229 | 87 | $57.22 | $13K |
| 99223 Hospital E&M - Initial | Facility | 174 | 150 | $120.34 | $21K |
| 99213 Office E&M - Established | Office | 136 | 129 | $41.72 | $5,673 |
| 78452 Myocardial Perfusion Scan | Office | 112 | 111 | $54.24 | $6,075 |
| 93018 Electrocardiogram | Office | 110 | 109 | $10.16 | $1,118 |
| 78452 Myocardial Perfusion Scan | Facility | 91 | 90 | $53.89 | $4,904 |
| 93018 Electrocardiogram | Facility | 83 | 82 | $9.97 | $827 |
| 93458 Percutaneous Transcatheterization | Facility | 69 | 69 | $145.24 | $10K |
| 93970 Duplex Scan - Extremity Veins | Office | 62 | 62 | $24.17 | $1,498 |
By year: 2022 $259K for 6,047 services; 2023 $256K for 5,679 services; 2024 $249K for 5,675 services.
Medicare prescription drug claims, 2024
In 2024, the drug John I Nwogu prescribed most often to Medicare patients was Metoprolol Succinate, with 995 prescriptions and refills. In total John I Nwogu wrote 9,903 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 995 | 2,751 | 347 | $16K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 712 | 1,984 | 261 | $9,999 |
| Atorvastatin Calcium Generic | 704 | 2,017 | 240 | $8,702 |
| Amlodipine Besylate Generic | 648 | 1,875 | 233 | $4,593 |
| Clopidogrel Clopidogrel Bisulfate | 639 | 1,832 | 224 | $7,968 |
| Eliquis Apixaban | 574 | 1,074 | 149 | $608K |
| Ranolazine Er Ranolazine | 530 | 1,296 | 178 | $56K |
| Furosemide Generic | 437 | 1,227 | 184 | $2,636 |
| Potassium Chloride Generic | 396 | 1,054 | 168 | $7,563 |
| Carvedilol Generic | 394 | 1,085 | 129 | $4,127 |
| Losartan Potassium Generic | 360 | 1,001 | 122 | $4,137 |
| Rosuvastatin Calcium Generic | 309 | 852 | 98 | $6,079 |
| Amiodarone Hcl Generic | 197 | 508 | 62 | $8,540 |
| Lisinopril Generic | 177 | 476 | 61 | $1,722 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 174 | 502 | 69 | $2,718 |
Brand drugs: 1,296 claims; generic drugs: 8,607 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John I Nwogu $319 ($319 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $61.53.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $61.53 |
| Pfizer Inc. PFE | 3 | $51.9 |
| Biotronik Inc. | 1 | $43.34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31.66 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21.88 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $21.51 |
| Boston Scientific Corporation BSX | 1 | $21.2 |
| Esperion Therapeutics, Inc. ESPR | 1 | $16.96 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $16.64 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.